☆ 4.2 Meeting Abstract

Efficacy and safety of upadacitinib in TNFi-IR patients with rheumatoid arthritis from three Phase 3 clinical trials

SWISS MEDICAL WEEKLY (2022)

Add to Collection

Journal

SWISS MEDICAL WEEKLY
Volume 152, Issue -, Pages 14S-16S

Publisher

E M H SWISS MEDICAL PUBLISHERS LTD

Keywords

-

Categories

Medicine, General & Internal

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.